Fort Washington Investment Advisors Adds $3M in CVS Health Corporation ($CVS)

Fort Washington Investment Advisors boosted its position in CVS Health Corporation (NYSE:CVS) by 3.7% during the first quarter of 2026. According to the latest Form 13F filing with the SEC, the firm added 26,818 shares, bringing its total holdings to 752,007 shares valued at approximately $76.7 million.

What Changed in Fort Washington Investment Advisors' CVS Health Position

Fort Washington Investment Advisors' decision to increase its stake in CVS Health reflects a positive outlook on the healthcare giant. The firm now holds 752,007 shares, up from 725,189 shares previously, with the additional shares valued at around $76.7 million.

Other Institutional Activity in CVS Health

Other major funds also adjusted their positions in CVS Health. BlackRock, Inc. grew its holdings by 4,925,379 shares, ending with 125,919,853 shares worth about $9.04 billion. Vanguard Capital Management LLC now holds 82,650,076 shares valued at $5.94 billion, having added the same number of shares. Capital World Investors increased its position by 9,585,731 shares to 77,248,642 shares, valued at $5.55 billion. Meanwhile, State Street Corp reduced its holdings by 861,562 shares, bringing its total to 59,322,181 shares worth $4.26 billion. Dodge & Cox also trimmed its stake by 10,729,872 shares to 51,780,116 shares, valued at $3.72 billion.

CVS Health Stock Snapshot

Shares of CVS Health (NYSE:CVS) are trading near $101.96. The company has a market cap of $128.5 billion, a P/E ratio of 44.16, and a forward P/E of 12.02. Its beta is 0.623, indicating relatively low volatility. The stock's 52-week range is between $58.5 and $102.77, with a 50-day moving average of $87.39 and a 200-day moving average of $79.83.

Recent Earnings

CVS Health reported revenue of $405.6 billion, reflecting a growth of 6.1%. The company achieved an earnings per share (EPS) of $2.28. It has a net margin of 0.723% and a return on equity (ROE) of 3.75%. The next earnings report is expected on July 30, 2026.

Dividend

CVS Health offers an annual dividend rate of $2.66, yielding 2.64%. The dividend payout ratio stands at 116.67%.

Insider Buying and Selling at CVS Health Corporation

Several insiders sold shares of CVS Health recently. On May 31, 2026, Amy Compton-Phillips, EVP and Chief Medical Officer, sold 7,618 shares at an average price of $90.98. Brian Newman, EVP and CFO, also sold 2,478 shares at the same price on the same day. Fernando Aguirre sold 1,563 shares at $93.50 and 30,437 shares at $93.78 on May 21. Larry Robbins sold 370,462 shares at $93.45 and 378,000 shares at $93.31 on May 21.

Analysts Set New Price Targets

Analysts remain optimistic about CVS Health. On June 8, 2026, Mizuho maintained a 'buy' rating with a price target of $115. Morgan Stanley also maintained a 'buy' rating with a $111 target on June 4. Other firms like Truist Securities and Barclays maintained 'buy' ratings with targets of $108 and $106, respectively. The consensus among analysts is a 'strong buy' with a mean target price of $104.50.

About CVS Health Corporation

CVS Health Corporation, based in Woonsocket, Rhode Island, provides health solutions in the U.S. It operates through segments like Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The company offers a range of insurance products and services, pharmacy benefit management, and sells prescription and over-the-counter drugs. Led by CEO J. David Joyner, CVS Health employs about 219,000 people.

Bottom Line

Fort Washington Investment Advisors' increased stake in CVS Health showcases investor confidence in the company's prospects. The 13F filing reflects holdings as of the first quarter of 2026, and may not indicate the firm's current position. Investors track such filings for insights into institutional sentiment, but they represent past, not current, holdings.